Abiopharma

🔍 STEVENS MARK A (Director)

Company: NVIDIA CORP (NVDA)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 1,211 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,544,612.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 5,207,271.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By the Envy Trust | shares_owned_after: 15,017,750.00 | Footnotes: F3

Footnotes:

• F1: Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.
• F2: Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.
• F3: Held by the Envy Trust u/a/d December 7, 2021, of which the Reporting Person is trustee.